Harvard Bioscience Subsidiary Data Sciences International Wins Award for Best Achievement of Operational Excellence in Pharmaceuticals & Life Sciences
April 03, 2019 17:18 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a division of Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a...
Harvard Bioscience To Showcase Products at Experimental Biology 2019
March 26, 2019 17:15 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., March 26, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, is...
Harvard Bioscience Reports Strong Fourth Quarter and Year-End 2018 Results, and Issues 2019 Financial Guidance
February 28, 2019 16:02 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance...
Harvard Bioscience Subsidiary Data Sciences International to Participate at SOT 2019 With Presentation and Exhibit
February 26, 2019 16:30 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a subsidiary of Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a...
Harvard Bioscience Schedules Fourth Quarter 2018 Conference Call for February 28 at 4:30 PM ET
February 19, 2019 16:05 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will...
Harvard Bioscience Presents Data, Symposium Session and New Products at Neuroscience 2018
November 02, 2018 14:30 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, is...
Harvard Bioscience Reports Third Quarter 2018 Financial Results
October 25, 2018 16:02 ET
|
Harvard Bioscience, Inc.
-Reports GAAP and adjusted non-GAAP revenue of $28.6 million and $28.7 million, respectively, an increase of 53% and 15%, respectively- HOLLISTON, Mass., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Harvard...
Harvard Bioscience Names Kam Unninayar as Chief Financial Officer
October 22, 2018 16:11 ET
|
Harvard Bioscience, Inc.
Seasoned Financial Executive With More Than a Decade in Global Life Science Instrumentation, Will Begin on November 26 HOLLISTON, Mass., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience,...
Harvard Bioscience Schedules Third Quarter 2018 Conference Call for October 25 at 4:30 PM ET
October 18, 2018 16:30 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will...
Harvard Bioscience Announces Management Change
August 22, 2018 08:30 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance...